KIT mutations and CD117 overexpression are markers of better progression-free survival in vulvar melanomas.
Dias-Santagata D, Selim MA, Su Y, Peng Y, Vollmer R, Chłopik A, Tell-Marti G, Paral KM, Shalin SC, Shea CR, Puig S, Fernandez-Figueras MT, Biernat W, Ryś J, Marszalek A, Hoang MP.
Dias-Santagata D, et al. Among authors: chlopik a.
Br J Dermatol. 2017 Nov;177(5):1376-1384. doi: 10.1111/bjd.15836. Epub 2017 Nov 5.
Br J Dermatol. 2017.
PMID: 28734009